Grantham Mayo Van Otterloo & Co. LLC cut its holdings in Leidos Holdings, Inc. (NYSE:LDOS - Free Report) by 16.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 18,930 shares of the aerospace company's stock after selling 3,805 shares during the period. Grantham Mayo Van Otterloo & Co. LLC's holdings in Leidos were worth $2,727,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also added to or reduced their stakes in the business. Duncker Streett & Co. Inc. bought a new position in Leidos in the fourth quarter worth approximately $27,000. Berbice Capital Management LLC acquired a new stake in Leidos in the 4th quarter valued at $29,000. Mather Group LLC. increased its stake in Leidos by 143.1% during the 4th quarter. Mather Group LLC. now owns 265 shares of the aerospace company's stock valued at $38,000 after purchasing an additional 156 shares in the last quarter. Human Investing LLC bought a new position in shares of Leidos in the fourth quarter valued at $52,000. Finally, Vision Financial Markets LLC acquired a new position in shares of Leidos during the fourth quarter valued at about $57,000. 76.12% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Leidos
In other news, Director Robert C. Kovarik, Jr. sold 1,511 shares of the business's stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $134.56, for a total transaction of $203,320.16. Following the completion of the transaction, the director now owns 6,408 shares of the company's stock, valued at approximately $862,260.48. The trade was a 19.08 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gary Stephen May sold 2,128 shares of Leidos stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $131.24, for a total transaction of $279,278.72. Following the sale, the director now owns 11,264 shares of the company's stock, valued at approximately $1,478,287.36. The trade was a 15.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.96% of the company's stock.
Leidos Stock Performance
Shares of NYSE:LDOS traded up $2.38 during trading on Friday, hitting $142.05. 1,073,575 shares of the company were exchanged, compared to its average volume of 1,201,385. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.21 and a quick ratio of 1.13. Leidos Holdings, Inc. has a 52-week low of $123.23 and a 52-week high of $202.90. The company has a market cap of $18.21 billion, a PE ratio of 15.37, a P/E/G ratio of 1.65 and a beta of 0.66. The stock has a 50 day moving average of $135.05 and a 200 day moving average of $152.06.
Leidos (NYSE:LDOS - Get Free Report) last posted its earnings results on Tuesday, February 11th. The aerospace company reported $2.37 earnings per share for the quarter, beating analysts' consensus estimates of $2.24 by $0.13. Leidos had a return on equity of 30.93% and a net margin of 7.53%. As a group, equities research analysts predict that Leidos Holdings, Inc. will post 10.62 EPS for the current year.
Leidos Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, March 28th. Shareholders of record on Friday, March 14th were issued a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 1.13%. The ex-dividend date of this dividend was Friday, March 14th. Leidos's payout ratio is 17.32%.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on LDOS. Wells Fargo & Company cut their price target on Leidos from $191.00 to $173.00 and set an "overweight" rating for the company in a research note on Tuesday, April 8th. StockNews.com cut Leidos from a "strong-buy" rating to a "buy" rating in a research note on Friday. Cantor Fitzgerald upgraded shares of Leidos to a "strong-buy" rating in a report on Tuesday, February 25th. UBS Group reduced their price objective on shares of Leidos from $162.00 to $156.00 and set a "neutral" rating for the company in a research report on Wednesday, February 12th. Finally, William Blair downgraded Leidos from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. Five analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Leidos has a consensus rating of "Moderate Buy" and a consensus price target of $180.00.
View Our Latest Stock Report on LDOS
About Leidos
(
Free Report)
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Recommended Stories

Before you consider Leidos, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Leidos wasn't on the list.
While Leidos currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.